D008495OccupationsH02.403.429.51552514110.523181Medical OncologyFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonInvestigational Cancer TherapeuticsLeukemiaPalliative Care & Rehabilitation MedicineSurgical OncologyMD AndersonVIVEKSUBBIAHVIVEK SUBBIAH9518SUBBIAH, VIVEKAssistant ProfessorHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorEDUARDOBRUERAEDUARDO BRUERA8804BRUERA, EDUARDOProfessorDAVIDHUIDAVID HUI9525HUI, DAVIDAssociate Professor74Professor10Assistant Professor14Associate ProfessorCHARLES MBALCHCHARLES M BALCH12712BALCH, CHARLES MProfessor5.983470.00451427525research area of0.9898050.034514945subject area for37438856Esbenshade AJ, Kahalley LS, Wistinghausen B, Cash T, Baertschiger RM, Zarnegar-Lumley S, Green A, Dhall G, COG Young Investigators CommitteePediatric blood & cancerChildren's Oncology Group's 2023 blueprint for research: Young investigators. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30567.Pediatr Blood Cancer2023-07-12T00:00:002023Children's Oncology Group's 2023 blueprint for research: Young investigators.37549914Bhatia S, Pappo AS, Acquazzino M, Allen-Rhoades WA, Barnett M, Borinstein SC, Casey R, Choo S, Chugh R, Dinner S, Ermoian R, Fair D, Federman N, Folbrecht J, Gandhi S, Germann J, Goldsby R, Hayashi R, Huang AY, Huang MS, Jacobs LA, Lee-Miller C, Link MP, Livingston JA, Lustberg M, Malogolowkin M, Oeffinger KC, Pratilas CA, Reed D, Skiles J, von Mehren M, Yeager N, Montgomery S, Hang LJournal of the National Comprehensive Cancer Network : JNCCNAdolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 08; 21(8):851-880.J Natl Compr Canc Netw2023-08-01T00:00:002023Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.37797646Garton EM, Cira MK, Loehrer PJ, Eldridge L, Frank A, Prakash L, Chang S, Salloum RG, Ciolino H, He M, Gopal S, Duncan KThe Lancet. OncologyGlobal oncology research and training at US National Cancer Institute-designated cancer centres: results of the 2021 Global Oncology Survey. Lancet Oncol. 2023 Oct; 24(10):e407-e414.Lancet Oncol2023-10-01T00:00:002023Global oncology research and training at US National Cancer Institute-designated cancer centres: results of the 2021 Global Oncology Survey.37963306Santos ES, Oliver TK, Lacchetti C, Geisel R, Wilfong LS, Fader AN, Eng CJCO oncology practiceDrug Shortages in Oncology: ASCO Clinical Guidance for Alternative Treatments. JCO Oncol Pract. 2024 Jan; 20(1):19-32.JCO Oncol Pract2023-11-14T00:00:002023Drug Shortages in Oncology: ASCO Clinical Guidance for Alternative Treatments.38307807Ledermann JA, Matias-Guiu X, Amant F, Concin N, Davidson B, Fotopoulou C, Gonz?lez-Martin A, Gourley C, Leary A, Lorusso D, Banerjee S, Chiva L, Cibula D, Colombo N, Croce S, Eriksson AG, Falandry C, Fischerova D, Harter P, Joly F, Lazaro C, Lok C, Mahner S, Marm? F, Marth C, McCluggage WG, McNeish IA, Morice P, Nicum S, Oaknin A, P?rez-Fidalgo JA, Pignata S, Ramirez PT, Ray-Coquard I, Romero I, Scambia G, Sehouli J, Shapira-Frommer R, Sundar S, Tan DSP, Taskiran C, van Driel WJ, Vergote I, Planchamp F, Sessa C, Fagotti AAnnals of oncology : official journal of the European Society for Medical OncologyESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease. Ann Oncol. 2024 Mar; 35(3):248-266.Ann Oncol2024-02-01T00:00:002024ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professor